AM-Pharma B.V. today announced that it has successfully completed enrollment of patients in its ongoing Phase 2 clinical trial evaluating ilofotase alfa for the prevention of cardiac ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback